{"name":"Yangtze River Pharmaceutical Group Co., Ltd.","slug":"yangtze-river-pharmaceutical-group-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOalRLQUIwQVFDeGJXQTF6T0gzQWVSZlNWMlhzNENPbjBGckJ5dVdUcE8zRUZNYk9IU0IyZXZVdzFLUG9uekxqOTNfT1g0R3BFMzJiOGotMHd4dWlqQjVXVjNoVXpkUUdPZlFQNmJ5bVlvc3FmQUJtYzlNcU1ESjhRY3FfNGZRXzMzTjBFWEpudWZROHZoOWZELTQ4RW1aVDdvTVItNTNLNS1HTkNBbTV0T0VEOEdKWnBJeHB3b25Ubw?oc=5","date":"2025-11-10","type":"pipeline","source":"Stock Titan","summary":"Alvotech (NASDAQ: ALVO) allowed to manufacture AVT06 in UK under SPC waiver - Stock Titan","headline":"Alvotech (NASDAQ: ALVO) allowed to manufacture AVT06 in UK under SPC waiver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNcG1IcVpOVExYUG1XSVNJaGFNNzJVcXFoWVJKMDFTaHBJNi1DX2dxOE80azlSUHdtRHIzNTZ6dXhEUXFDcl9HVGYxRWZpekVTY1MtVXRqV2lkb2l5bEFWZlQzbE5lT2pSY3BDaU1nQkllOEZ1Snk3Q3lnb1dPRzdPWkR6ZFVKLW1YUWZsZHgxS2ZMa0JybXBmcXlOdXRfTThuX0JwMkhBVGhhTU1lNEVwODBjM1pQQjRKb2NBeXl4V1pVZEI4NW1URVNlajQ5ZVZKcWtEb3o1eVgtdkh3TXhSTFhScEpZaGlUdUhtR09zU2JFY0Q3VllKa00ySXRqMVV4WlJEN0tQbmtKalp6U2dCaEpxblhJYzJTVDEwTXU0OXNWNWxQbXJ5Wk5XRk9jY3FqY3EyaElUdUI?oc=5","date":"2025-11-06","type":"patent","source":"Finansavisen","summary":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - Finansavisen","headline":"Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxQSmJEVEN3MFkwLTVUaE5VMmR1Ml9zZUM1VUlFSGFPMHlRUnNqZVJjRk0tU0dmUl9JVk14bFJEUFJ1QWQyR3l6UnBza0JDcFQyMDZfb25PRXRaRjFuWW9pU0lqOTdJN3NuaGp0Y3hZbVpaMVZWcFVwaGExTGhHeVA1dzJjeTVyYndkTFRMaFNHY3lCQUpQcGNsY0x0LXF5d2hyRExWcElDcThXeDdKSngxTUxNR0xtaWJJck54b1F1OWxkYlJNeG9Ha2kzU2dFN19oUE9zWFVVLU1lNnF3UlNnUGp0Q3ZDelNpVS00bDlOUWV2d0xMV2toNkFwUEFmYTZqeFU4cDc5UHg4SktSZDM1SXRZZEhnVWZRWTE3QkxoZFFFWHRJMG9INWxMQVNDRTBKaUdjR1NFd05zNXpvQmRhMU5pLV80TEl0Q2tHeA?oc=5","date":"2025-11-04","type":"pipeline","source":"Finansavisen","summary":"Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update - Finansavisen","headline":"Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNNW5WZUtpWlBGeW9aUC1YVTdTU3kwcGRGalA3ZjZsQll4SHhRQVFTSV9nVkU3WHoyZHlCYzJZU1Jab0thQjkyb0FkLWYwZ1AzN3VIT2RQclR5emNmazctYk1RNVRteFN6ZG1jRU1KdTJyQUVQUjN2eWdjNlhoVEFpWjdEWkFISk9FLVJLbWRTYlNMMkR0S2RvZEs2LWM2NVlRZE5wVkU3UDE1SWhMWEVsWl9xWkowVDlaVlBhY2hwS1hjQWJWX0psdG43XzBHVlFWOXc?oc=5","date":"2025-10-22","type":"pipeline","source":"Quiver Quantitative","summary":"Alvotech Announces Key Leadership Changes in Global Business Development and Commercial Operations Team - Quiver Quantitative","headline":"Alvotech Announces Key Leadership Changes in Global Business Development and Commercial Operations Team","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-07","type":"regulatory","source":"BioSpace","summary":"Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar ","headline":"Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorizat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOd1p5eUVSN2hiWWtQVTRtdUpxaWExSXZ6OHJfd3U4eFVrWFdxeGtLMlNUa2diSFZBeFZ2bTJQb1U4Z3pVNDQzRldaMUhtSVQ1bHZMY0FabXZaOUhBNFV3bDI1NEdnWC0zaXhuWmRmRXFVMzJIc29hMmlFeU5Pd0QxYzRUWTkzbVE?oc=5","date":"2025-09-19","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNcl9IN054Y0wyVzA2NzNPcWwxY3czY1lYblBNblJpZlJMRnJrblV6a0U3emdqNE5tNFAwMnFXR2hMT1B0cW9TeEVzZl8tMG1MbjVqVTUwZWVzM3U0dzF6N2xQREZ2WGthVWpRblg4d3dXLVJXVHMtQVNWaFEwdE5XTUJPaERqa0NYLU9HbFg3SXdvYmZmNl9mQ09ZMElDRkE?oc=5","date":"2025-07-04","type":"pipeline","source":"ThinkChina","summary":"The rise and fall of China’s ‘fentanyl king’ in corruption-fuelled bankruptcy - ThinkChina","headline":"The rise and fall of China’s ‘fentanyl king’ in corruption-fuelled bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOeHRzNllCM3BDcmR6NGtpaUlMWkdtWmtlQVpCbERvYm9qQUpoMWE1WHNWYlZLbHkyd3JsUFlJMW5uSTFETl9Ud1NHVE1oWXMxWEF3UmVTUmNWUzFHV1c1bElCT203akIzUEhaeDF3Mm1wRUZ3b3ctN3NFanoyZWd4dG44endObkY3bkoyZEtR?oc=5","date":"2025-03-01","type":"trial","source":"Market Data Forecast","summary":"China Over the Counter Drugs Market Size & Growth, 2033 - Market Data Forecast","headline":"China Over the Counter Drugs Market Size & Growth, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQSUdmOW12Qi1lZTUwZVAtajBMcmxocTNzNFdFQUU4T05zaXY3MXRuR0Mxdmc5MWlpNld2TmpOcTVnby02NjhCY2JZMUdZZEVjMVRBcW5PUXZjTFdCWmEyZG91bjRkTHBnNEhSSmVGc01CNjFZVmk1c1NrUks5TllJZlI4ZWp4cnZyVnp1M1YxT09DWXRqYnMxYmM0d1hZVXVheThlWGdDTUtEWUNrdWFVeUVONE83Y0xmZGNMZjduR1dJbDJ6TDdIZVBfRWpkeS1mN080eTd2MFI5QXhmcHBIRG9PLVV0ZnhVUENVQ0RETlZ1QWxQ?oc=5","date":"2022-09-07","type":"patent","source":"lupin.com","summary":"Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines - Lupin | Press Release - lupin.com","headline":"Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNU0JBOEdobDVwVzQxLThKZVVzYVZyaklXVWpfR2ZSLXRFSGdzNDR0b2dDbEJaQXZEb3lla1lISXQtR2k5dmNPY2NFb3owUUhWMEpwanRIN1J1ZWYxMDFOOVQzZHhYN3l1cW1XQWE0NzFRZ2dJeFNVX205cWQ1ckRLYWpUcWhhNEU5bnFHYmNrZDBkdHp6bGtjN2d3ZXhGVFl1dU51T0xxamhvVTBxWXdhUHE2X0pwTmVzZnEtNW1HeG9iQQ?oc=5","date":"2021-04-15","type":"pipeline","source":"news.cgtn.com","summary":"Yangtze River Pharma Group fined $117m for monopolistic practices - news.cgtn.com","headline":"Yangtze River Pharma Group fined $117m for monopolistic practices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5jZjRBTUhhVEZZOFgydlJkcEwxUjlOYmRGSHdqRVlyc0xBZHRCUzgtQjZaLVdUaFBqZE5vaDNMUjJMRjJaUUROUTgwb2hMMkJOcDhOaVBJRVBnZ1lvVGc?oc=5","date":"2019-12-23","type":"pipeline","source":"新华丝路","summary":"Yangtze River Pharmaceutical Group - 新华丝路","headline":"Yangtze River Pharmaceutical Group - 新华丝路","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQNG01OUZUaGZ0YjVLSEFGeXJVZWtfdmpOZkFCb254Nm1pVVE4Ynh2bUdvOENDU1BBbl81TkVaYS1MUlEzaXpnc0U3dDN3VmtKTUlZYzhpY1BmcDBrWXBOVWF0OEpucGxGRl9YV0R6VUlnd0w4Yk1SX2dka1dxTVdWWVUyOERfUnN3aEdTbTU3MzBsbnZLZGs4ZA?oc=5","date":"2019-06-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"China pharmaceutical industry 2019: focus on Shandong and Jiangsu - Pharmaceutical Technology","headline":"China pharmaceutical industry 2019: focus on Shandong and Jiangsu","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}